Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Sep;38(9):2187–2190. doi: 10.1128/aac.38.9.2187

Effect of bismuth subsalicylate on ciprofloxacin bioavailability.

L Rambout 1, J Sahai 1, K Gallicano 1, L Oliveras 1, G Garber 1
PMCID: PMC284708  PMID: 7811043

Abstract

A single oral dose of 528 mg of bismuth subsalicylate (30 ml of Pepto-Bismol) had no significant effect on the plasma pharmacokinetics of a single oral dose of 750 mg of ciprofloxacin administered to 12 healthy volunteers (six men and six women). These results suggest that ciprofloxacin bioavailability will not be significantly decreased by single doses of bismuth subsalicylate when the two medications are administered simultaneously.

Full text

PDF
2190

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert K. S., Welch R. D., DeSante K. A., DiSanto A. R. Decreased tetracycline bioavailability caused by a bismuth subsalicylate antidiarrheal mixture. J Pharm Sci. 1979 May;68(5):586–588. doi: 10.1002/jps.2600680518. [DOI] [PubMed] [Google Scholar]
  2. Brouwers J. R. Drug interactions with quinolone antibacterials. Drug Saf. 1992 Jul-Aug;7(4):268–281. doi: 10.2165/00002018-199207040-00003. [DOI] [PubMed] [Google Scholar]
  3. Campbell N. R., Kara M., Hasinoff B. B., Haddara W. M., McKay D. W. Norfloxacin interaction with antacids and minerals. Br J Clin Pharmacol. 1992 Jan;33(1):115–116. doi: 10.1111/j.1365-2125.1992.tb04010.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ericsson C. D., Feldman S., Pickering L. K., Cleary T. G. Influence of subsalicylate bismuth on absorption of doxycycline. JAMA. 1982 Apr 23;247(16):2266–2267. [PubMed] [Google Scholar]
  5. Frost R. W., Lasseter K. C., Noe A. J., Shamblen E. C., Lettieri J. T. Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin. Antimicrob Agents Chemother. 1992 Apr;36(4):830–832. doi: 10.1128/aac.36.4.830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gallicano K., Sahai J., Zaror-Behrens G., Pakuts A. Effect of antacids in didanosine tablet on bioavailability of isoniazid. Antimicrob Agents Chemother. 1994 Apr;38(4):894–897. doi: 10.1128/aac.38.4.894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hauschke D., Steinijans V. W., Diletti E. A distribution-free procedure for the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol. 1990 Feb;28(2):72–78. [PubMed] [Google Scholar]
  8. Hooper D. C., Wolfson J. S. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Antimicrob Agents Chemother. 1985 Nov;28(5):716–721. doi: 10.1128/aac.28.5.716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Midha K. K., Ormsby E. D., Hubbard J. W., McKay G., Hawes E. M., Gavalas L., McGilveray I. J. Logarithmic transformation in bioequivalence: application with two formulations of perphenazine. J Pharm Sci. 1993 Feb;82(2):138–144. doi: 10.1002/jps.2600820205. [DOI] [PubMed] [Google Scholar]
  10. Nix D. E., Watson W. A., Handy L., Frost R. W., Rescott D. L., Goldstein H. R. The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin. Pharmacotherapy. 1989;9(6):377–380. doi: 10.1002/j.1875-9114.1989.tb04152.x. [DOI] [PubMed] [Google Scholar]
  11. Polk R. E. Drug-drug interactions with ciprofloxacin and other fluoroquinolones. Am J Med. 1989 Nov 30;87(5A):76S–81S. doi: 10.1016/0002-9343(89)90028-4. [DOI] [PubMed] [Google Scholar]
  12. Polk R. E., Healy D. P., Sahai J., Drwal L., Racht E. Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother. 1989 Nov;33(11):1841–1844. doi: 10.1128/aac.33.11.1841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sahai J., Gallicano K., Oliveras L., Khaliq S., Hawley-Foss N., Garber G. Cations in the didanosine tablet reduce ciprofloxacin bioavailability. Clin Pharmacol Ther. 1993 Mar;53(3):292–297. doi: 10.1038/clpt.1993.24. [DOI] [PubMed] [Google Scholar]
  14. Sahai J., Healy D. P., Stotka J., Polk R. E. The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin. Br J Clin Pharmacol. 1993 Mar;35(3):302–304. [PMC free article] [PubMed] [Google Scholar]
  15. Tanaka M., Kurata T., Fujisawa C., Ohshima Y., Aoki H., Okazaki O., Hakusui H. Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide. Antimicrob Agents Chemother. 1993 Oct;37(10):2173–2178. doi: 10.1128/aac.37.10.2173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wagstaff A. J., Benfield P., Monk J. P. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. Drugs. 1988 Aug;36(2):132–157. doi: 10.2165/00003495-198836020-00002. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES